Study of NGEP expression in androgen sensitive prostate cancer cells: A potential target for immunotherapy

Authors

  • Mehdi Shekarabi Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Mohammad M Farajollahi Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran, Department of Medical Biotechnology, School of Allied Medical Sciences, Iran University of Medical Sciences, Tehran, Iran & Food and Drug Laboratory, Fardis, Alborz, Iran.
  • Monireh Mohsenzadegan Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran & Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran.
  • Nader Tajik Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran & Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran.
  • Zahra Madjd Oncopathology Research Centre and Department of Pathology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Abstract:

  Background: Prostate cancer is one of the leading causes of cancer deaths among men. New gene expressed in prostate (NGEP), is a prostate-specific gene expressed only in normal prostate and prostate cancer tissue. Because of its selective expression in prostate cancer cell surface, NGEP is a potential immunotherapeutic target. To target the NGEP in prostate cancer, it is essential to investigate its expression in prostate cancer cells.   Methods : In the present study, we investigated NGEP expression in LNCaP and DU145 cells by real time and RT-PCR, flow cytometric and immunocytochemical analyses.   Results : Real time and RT-PCR analyses of NGEP expression showed that NGEP was expressed in the LNCaP cells but not in DU145 cells. The detection of NGEP protein by flow cytometric and immunocytochemistry analyses indicated that NGEP protein was weakly expressed only in LNCaP cell membrane.   Conclusion : Our results demonstrate that LNCaP cell line is more suitable than DU145 for NGEP expression studies however, its low-level expression is a limiting issue. NGEP expression may be increased by androgen supplementation of LNCaP cell culture medium.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

study of ngep expression in androgen sensitive prostate cancer cells: a potential target for immunotherapy

background: prostate cancer is one of the leading causes of cancer deaths among men. new gene expressed in prostate (ngep), is a prostate-specific gene expressed only in normal prostate and prostate cancer tissue. because of its selective expression in prostate cancer cell surface, ngep is a potential immunotherapeutic target. to target the ngep in prostate cancer, it is essential to investigat...

full text

Androgen receptor as a licensing factor for DNA replication in androgen-sensitive prostate cancer cells.

Androgen receptor (AR) protein expression and function are critical for survival and proliferation of androgen-sensitive (AS) prostate cancer cells. Besides its ability to function as a transcription factor, experimental observations suggest that AR becomes a licensing factor for DNA replication in AS prostate cancer cells and thus must be degraded during each cell cycle in these cells to allow...

full text

ERR; Suppresses Cell Proliferation and Tumor Growth of Androgen-Sensitive and Androgen-Insensitive Prostate Cancer Cells and Its Implication as a Therapeutic Target for Prostate Cancer

Estrogen receptor-related receptors (ERR) are orphan nuclear receptors, which are constitutively activated without estrogen binding. Recent evidence indicates that the ligand-independent ERRs may be involved in similar ER-mediated regulatory pathways and modulate estrogen responsiveness in certain target cells. We recently showed that an ERR subtype, ERR;, is coexpressed with ERB in normal huma...

full text

ERRgamma suppresses cell proliferation and tumor growth of androgen-sensitive and androgen-insensitive prostate cancer cells and its implication as a therapeutic target for prostate cancer.

Estrogen receptor-related receptors (ERR) are orphan nuclear receptors, which are constitutively activated without estrogen binding. Recent evidence indicates that the ligand-independent ERRs may be involved in similar ER-mediated regulatory pathways and modulate estrogen responsiveness in certain target cells. We recently showed that an ERR subtype, ERRgamma, is coexpressed with ERbeta in norm...

full text

A promoting role of androgen receptor in androgen-sensitive and -insensitive prostate cancer cells

Although the vital role of the androgen receptor (AR) has been well demonstrated in primary prostate cancers, its role in the androgen-insensitive prostate cancers still remains unclear. Here, we used a small hairpin RNA approach to directly assess AR activity in prostate cancer cells. Reduction of AR expression in the two androgen-sensitive prostate cancer cell lines, LNCaP and LAPC4, signific...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 29  issue 1

pages  1- 7

publication date 2015-01

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023